Advances in Drug Delivery in Dermatology
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 10 June 2024 | Viewed by 99
Special Issue Editors
Interests: laser-assisted drug delivery; laser-induced immunoactivation; translational research in dermatology
Special Issue Information
Dear Colleagues,
In the dynamic landscape of dermatological therapeutics, the field of drug delivery plays a pivotal role in the design of new treatment approaches and improving patient outcomes. The myriad of different dermatological conditions and the complex physiology of skin and its appendages present unique challenges and opportunities for drug delivery systems. Recent advances in nanotechnology, formulation science, and device-assisted delivery have propelled the development of targeted and safe treatment options for various inflammatory, oncological, and infectious conditions in dermatology. Understanding the complex interplay of cutaneous physiology and therapeutic agents is essential for optimizing treatment efficacy while minimizing side effects to ensure compliance and satisfactory outcomes.
This Special Issue seeks to explore recent advancements in cutaneous, follicular, and ungual drug delivery for dermatological applications and provide a platform for scientists, clinicians, and industry experts to share insights and achievements in the field that enhance drug permeation, prolong drug release, and improve patient safety and compliance in dermatological treatments.
Contributions are invited across a spectrum of themes, including, but not limited to, novel formulations, permeation enhancement strategies, and targeted delivery for various dermatological conditions. Special consideration will be given to original research, including clinical trials of all phases as well as preclinical and translational studies. Reviews and meta-analyses exploring the efficacy and safety of drug delivery systems are also encouraged.
We look forward to receiving your contributions.
Dr. Uffe Høgh Olesen
Dr. Vinzent Kevin Ortner
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- topical drug delivery
- ungual drug delivery
- laser-assisted drug delivery
- ultrasound-assisted drug delivery
- needle injection
- needle-free injection
- drug delivery enhancers
- transdermal delivery
- nanocarriers
- topical formulations
- microneedle technology
- controlled release
- biomaterials
- targeted delivery
- dermatology therapeutics
- formulation science
- skin physiology
- drug release kinetics
- encapsulation
- dermatological conditions
- therapeutic efficacy
- innovative drug delivery systems
- pre-clinical models
- animal models
- randomized controlled trials
- case-control studies
- systematic reviews
- narrative reviews
- meta-analyses
